Product information

Atripla 600 mg - 200 mg - 245 mg
30
efavirenz 600 mg + emtricitabine 200 mg + tenofovir disoproxil 245 mg tablet (or.)
2647071
0 / 10
Locked

Product properties

154598-52-4
J05AR06
Gilead Sciences Ireland UC
Film-coated tablet
EU/1/07/430/001
05391507140265
M42
Public
314982-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Revocation of the authorisation) and no stock is available from wholesalers. Switching to an alternative is necessary.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

No status history available.

Composition

3 ingredients

Substance Type Strength CAS
Active ingredient
202138-50-9
Active ingredient
600 mg
154598-52-4
Active ingredient
200 mg
143491-57-0

Additional information

View on BCPI

Availability statistics

Unknown
0 days
0
0